SEC Filing Summary: Amesite Inc. (AMST)
Business Context and Reporting Period
This Form 8-K was filed by Amesite Inc. on October 29, 2025, reporting an event that occurred on October 28, 2025. The Company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol "AMST". The filing addresses a regulatory notice regarding continued listing compliance.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. However, it explicitly states that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1) due to failing to maintain the required minimum of $2,500,000 in stockholders' equity. Additionally, the Company failed to meet alternative listing standards, which include a market value of listed securities of at least $35 million or net income of $500,000 from continuing operations in the most recently completed fiscal year (or two of the three most recent fiscal years).
Material Changes and Listing Status
On October 28, 2025, Amesite Inc. received a deficiency letter from Nasdaq notifying it of non-compliance with the Stockholders' Equity Requirement and alternative listing standards. This notice does not immediately affect the listing or trading of the Company's common shares, which will continue to trade on the Nasdaq Capital Market.
Outlook, Management Commentary, and Risks
- Compliance Plan: The Company has 45 calendar days from the date of the Nasdaq Letter to submit a plan to regain compliance. It intends to submit this plan within the allotted period.
- Extension Possibility: If Nasdaq accepts the plan, the Company may be granted an extension of up to 180 calendar days to evidence compliance.
- Delisting Risk: If the plan is not accepted, or if the Company fails to regain compliance within the extension period, the Company may face delisting. In such cases, the Company has the right to a hearing before an independent panel, which would stay any suspension or delisting action pending the conclusion of the process.
- Management Stance: Management intends to take all reasonable measures to regain compliance but notes there is no assurance that Nasdaq will grant an extension or that compliance will ultimately be achieved.
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ from expectations due to inherent business risks.
Key Facts for Investor Verification
- Verify the Company's current stockholders' equity balance to confirm the specific shortfall below the $2.5 million threshold.
- Monitor the submission of the compliance plan within the 45-day window following October 28, 2025.
- Track Nasdaq's decision on the acceptance of the compliance plan and any granted extension period.
- Review the Company's most recent audited financial statements to assess the net income and market value of listed securities relative to the alternative listing standards.
- Watch for any subsequent filings regarding the outcome of the compliance plan or potential hearing requests.